A Phase 3, Multicenter, Randomized, Double-blind, Double

Project: Research project

Project Details

Description

A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant R
StatusActive
Effective start/end date8/1/1612/31/20

Funding

  • SHIRE HUMAN GENETIC THERAPIES, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.